Notice: This company has been marked as potentially delisted and may not be actively trading. Agile Therapeutics (AGRX) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Agile Therapeutics, Inc.: Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.August 27, 2024 | finanznachrichten.deAgile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.August 26, 2024 | globenewswire.comAgile Leadership for Pharma and Biopharma Professionals in a Hybrid World: 2-Day Training Course (Online) November 18-19, 2024 - Become Competent and Familiar in a Range of Well-Recognised Leadership TechniquesAugust 7, 2024 | globenewswire.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Agile Therapeutics, Inc. - AGRXJuly 3, 2024 | prnewswire.comAGRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Agile Therapeutics, Inc. Is Fair to ShareholdersJune 26, 2024 | businesswire.comAgile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.June 26, 2024 | globenewswire.comAgile Therapeutics, Inc.: Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 16, 2024 | finanznachrichten.deAGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024May 16, 2024 | investorplace.comAgile Therapeutics: Q1 Earnings SnapshotMay 15, 2024 | sfgate.comAgile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 15, 2024 | finance.yahoo.comAgile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 15, 2024 | globenewswire.comAgile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call TranscriptApril 1, 2024 | finance.yahoo.comAgile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call TranscriptMarch 30, 2024 | seekingalpha.comAGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023March 29, 2024 | investorplace.comQ4 2023 Agile Therapeutics Inc Earnings CallMarch 29, 2024 | finance.yahoo.comHere's what to expect from Agile Therapeutics's earnings reportMarch 28, 2024 | markets.businessinsider.comAgile Therapeutics, Inc.: Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate UpdateMarch 28, 2024 | finanznachrichten.deAgile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate UpdateMarch 28, 2024 | globenewswire.comWhy Agile Therapeutics (AGRX) Stock Is Down 60%March 26, 2024 | msn.comAgile Therapeutics, Inc.: Agile Therapeutics Announces Delisting from NasdaqMarch 26, 2024 | finanznachrichten.deAgile Therapeutics Announces Delisting from NasdaqMarch 25, 2024 | globenewswire.comLatest News for Agile Therapeutics Stock (NASDAQ:AGRX)March 23, 2024 | benzinga.comAgile Therapeutics is about to announce its earnings — here's what to expectMarch 21, 2024 | markets.businessinsider.comAgile Therapeutics's Earnings: A PreviewMarch 21, 2024 | benzinga.comCorrection - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024March 21, 2024 | globenewswire.comAgile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024March 20, 2024 | globenewswire.comAgile Therapeutics stock soars on complete debt payoffMarch 13, 2024 | msn.comAgile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan ExecutionMarch 13, 2024 | globenewswire.comAgile Therapeutics reduces warrant exercise priceFebruary 24, 2024 | investing.comAgile Therapeutics Stock (NASDAQ:AGRX), Short Interest ReportFebruary 22, 2024 | benzinga.comWhat's Going On With Women Health Focused Agile Therapeutics Stock Today?February 22, 2024 | benzinga.comAgile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross ProceedsFebruary 22, 2024 | finance.yahoo.comWhy Is Agile Therapeutics (AGRX) Stock Up 87% Today?February 22, 2024 | investorplace.comAgile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross ProceedsFebruary 22, 2024 | globenewswire.comWhy Is Agile Therapeutics (AGRX) Stock Up 87% Today?February 22, 2024 | investorplace.comAgile Therapeutics reports higher prelim FY revenue than last yearFebruary 15, 2024 | msn.comAgile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance UpdateFebruary 15, 2024 | finance.yahoo.comAgile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders' Equity Continued Listing Requirement & Provides Performance UpdateFebruary 15, 2024 | globenewswire.comBuy Rating for Agile Therapeutics: Regulatory Tailwinds and Strong Sales Growth ForecastJanuary 25, 2024 | markets.businessinsider.comThe Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without CostJanuary 23, 2024 | finance.yahoo.comAgile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage RequirementDecember 12, 2023 | finance.yahoo.comAgile Therapeutics reports Q3 resultsNovember 23, 2023 | msn.comAgile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024November 21, 2023 | benzinga.comAgile Therapeutics: A Promising Investment with Positive Cash Flow Forecasts and Anticipated Growth in Twirla SalesNovember 11, 2023 | markets.businessinsider.comAgile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | finance.yahoo.comAgile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 9, 2023 | finance.yahoo.comAgile Therapeutics Q3 2023 Earnings PreviewNovember 8, 2023 | msn.comAgile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023October 26, 2023 | finance.yahoo.comAgile Therapeutics, Inc.: Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)October 5, 2023 | finanznachrichten.deAgile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)October 4, 2023 | finance.yahoo.com Get Agile Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address AGRX Media Mentions By Week AGRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGRX News Sentiment▼0.000.69▲Average Medical News Sentiment AGRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGRX Articles This Week▼01▲AGRX Articles Average Week Get Agile Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Tempest Therapeutics News Today Iterum Therapeutics News Today VYNE Therapeutics News Today RAPT Therapeutics News Today Barinthus Biotherapeutics News Today Actinium Pharmaceuticals News Today CASI Pharmaceuticals News Today Q32 Bio News Today Anebulo Pharmaceuticals News Today SCYNEXIS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGRX) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon’s ultimate power move?THE ELON SHOCK All of Elon Musk’s strange behavior may soon make sense… and impact the markets in a way no ...Altimetry | SponsoredNew catalyst on Wall Street’s radar for this week (NOT Trump)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger ...Timothy Sykes | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agile Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agile Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
